Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 4 Grant or award Director acquired 1,036 shares (grant or award)
  2. 4 Grant or award Director acquired 1,810 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy Director bought 1,000 shares at $8.03 ($8,030)
  9. 4 Exercise or conversion President & CEO acquired 4,400 shares (option exercise)
  10. 4 Exercise or conversion Chief Medical Officer acquired 4,400 shares (option exercise)
  11. 4 Grant or award Director acquired 1,364 shares (grant or award)
  12. 4 Grant or award Director acquired 2,414 shares (grant or award)
  13. 4 Grant or award Director acquired 717 shares (grant or award)
  14. 4 Grant or award Director acquired 1,504 shares (grant or award)
  15. 4/A Insider Changes in Ownership
  16. 4 Grant or award Chief Financial Officer acquired 1,002 shares (grant or award)
  17. 4 Grant or award President & CEO acquired 350 shares (grant or award)
  18. 4 Grant or award Chief Medical Officer acquired 2,485 shares (grant or award)
  19. 4 Exercise or conversion Chief Medical Officer acquired 1,500 shares (option exercise)
  20. 4 Exercise or conversion Chief Financial Officer acquired 1,503 shares (option exercise)

Page 13 of 37 · 739 filings